| Vaccine | Type of Vaccine1 | Date vaccine given (mo/day/yr) | Funding Source (F,S,P)2 | Route3 and Site3 | Vaccine | Vaccine Information Statement (VIS) | Vaccinator5 (signature or initials and title) |
| Lot # | Mfr. | Date on VIS4 | Date given4 |
| Tetanus, Diphtheria, Pertussis (e.g., Tdap, Td) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Hepatitis A6 (e.g., HepA, HepA-HepB) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Hepatitis B6 (e.g., HepB, HepA-HepB) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Human papillomavirus (HPV2, HPV4, HPV9) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Measles, Mumps, Rubella (MMR) Give Subcut.3 | | | | | | | | | |
| | | | | | | | |
| Varicella (VAR) Give Subcut.3 | | | | | | | | | |
| | | | | | | | |
| Meningococcal ACWY (e.g., MenACWY [MCV4], MPSV4) Give MenACWY IM.7 Give MPSV4 Subcut.7 | | | | | | | | | |
| | | | | | | | |
| Meningococcal B (e.g., MenB) Give MenB IM.7 | | | | | | | | | |
| | | | | | | | |
See page 2 to record influenza, pneumococcal, zoster, Hib, and other vaccines (e.g., travel vaccines).
## How to Complete this Record
1. Record the generic abbreviation (e.g., Tdap) or the trade name for each vaccine (see table at right).
2. Record the funding source of the vaccine given as either F (federal), S (state), or P (private).
3. Record the route by which the vaccine was given as either intramuscular (IM), subcutaneous (Subcut), intradermal (ID), intranasal (NAS), or oral (PO) and also the site where it was administered as either RA (right arm), LA (left arm), RT (right thigh), or LT (left thigh).
4. Record the publication date of each VIS as well as the date the VIS is given to the patient.
5. To meet the space constraints of this form and federal requirements for documentation, a healthcare setting may want to keep a reference list of vaccinators that includes their initials and titles.
6. For combination vaccines, fill in a row for each antigen in the combination.
| Abbreviation | Trade Name and Manufacturer |
| Tdap | Adacel (Sanofi Pasteur); Boostrix (GlaxoSmithKline [GSK]) |
| Td | Decavac, Tenivac (Sanofi Pasteur); generic Td (MA Biological Labs) |
| HepA | Havrix (GSK); Vaqta (Merck) |
| HepB | Engerix-B (GSK); Recombivax HB (Merck) |
| HepA-HepB | Twinrix (GSK) |
| HPV2 | Cervarix (GSK) |
| HPV4, HPV5 | Gardasil, Gardasil 9 (Merck) |
| MMR | MMRII (Merck) |
| VAR | Varivax (Merck) |
| MenACWY | Menactra (Sanofi Pasteur); Menveo (GSK) |
| MPSV4 | Menomune (Sanofi Pasteur) |
| MenB | Bexsero (GSK); Trumenba (Pfizer) |
===== PAGE 2 =====
## Vaccine Administration Record for Adults (continued)
Before administering any vaccines, give the patient copies of all pertinent Vaccine Information Statements (VISs) and make sure he/she understands the risks and benefits of the vaccine(s). Always provide or update the patient's personal record card.
Patient name___
Birthdate ___ Chart number ___
PRACTICE NAME AND ADDRESS
| Vaccine | Type of Vaccine1 | Date vaccine given (mo/day/yr) | Funding Source (F,S,P)2 | Route3 and Site3 | Vaccine | Vaccine Information Statement (VIS) | Vaccinator5 (signature or initials and title) |
| Lot # | Mfr. | Date on VIS4 | Date given4 |
| Influenza (e.g., IIV3, IIV4, ccIIV3, RIV3, LAIV4) | | | | | | | | | |
| Give IIV3, IIV4, ccIIV3, and RIV3 IM.3 | | | | | | | | | |
| Give LAIV4 NAS.3 | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Pneumococcal conjugate (e.g., PCV13) Give PCV13 IM.3 | | | | | | | | | |
| Pneumococcal polysaccharide (e.g., PPSV23) Give PPSV23 IM or Subcut.3 | | | | | | | | | |
| Zoster (HZV) Give Subcut.3 | | | | | | | | | |
| Hib Give IM.3 | | | | | | | | | |
| Other | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
See page 1 to record Tdap/Td, hepatitis A, hepatitis B, HPV, MMR, varicella, MenACWY, and MenB vaccines.
## How to Complete this Record
1. Record the generic abbreviation (e.g., Tdap) or the trade name for each vaccine (see table at right).
2. Record the funding source of the vaccine given as either F (federal), S (state), or P (private).
3. Record the route by which the vaccine was given as either intramuscular (IM), subcutaneous (Subcut), intradermal (ID), intranasal (NAS), or oral (PO) and also the site where it was administered as either RA (right arm), LA (left arm), RT (right thigh), or LT (left thigh).
4. Record the publication date of each VIS as well as the date the VIS is given to the patient.
5. To meet the space constraints of this form and federal requirements for documentation, a healthcare setting may want to keep a reference list of vaccinators that includes their initials and titles.
| Abbreviation | Trade Name and Manufacturer |
| IIV3 (inactivated influenza vaccine, trivalent); IIV4 (inactivated influenza vaccine, quadrivalent); ccIIV3 (cell culture-based inactivated influenza vaccine, trivalent); RIV3 (inactivated recombinant influenza vaccine, trivalent) | Fluarix (GSK); Flublok (Protein Sciences Corp.); Afluria, Fluad, Flucelvax, Fluvirin (Seqirus); FluLaval (GSK); Fluzone, Fluzone Intradermal, Fluzone High-Dose (Sanofi Pasteur) |
| LAIV (live attenuated influenza vaccine, quadrivalent) | FluMist (MedImmune) |
| PCV13 | Prevnar 13 (Pfizer) |
| PPSV23 | Pneumovax 23 (Merck) |
| HZV (shingles) | Zostavax (Merck) |
| Hib | ActHIB (Sanofi Pasteur); Hiberix (GSK); PedvaxHib (Merck) |
===== PAGE 3 =====
IMMUNIZATION ACTION COALITION Saint Paul, Minnesota · 651-647-9009 · www.immunize.org · www.vaccineinformation.org
## Vaccine Administration Record for Adults
Before administering any vaccines, give the patient copies of all pertinent Vaccine Information Statements (VISs) and make sure he/she understands the risks and benefits of the vaccine(s). Always provide or update the patient's personal record card.
| Vaccine | Type of Vaccine1 | Date vaccine given (mo/day/yr) | Funding Source (F,S,P)2 | Route3 and Site3 | Vaccine | Vaccine Information Statement (VIS) | Vaccinator5 (signature or initials and title) |
| Lot # | M/F | Date on VIS4 | Date given4 |
| Tetanus, Diphtheria, Pertussis (e.g., Tdap, Td) Give IM.3 | Td | 8/1/2002 | P | IM/LA | U0376AA | A/P | 6/10/1994 | 8/1/2002 | JTA |
| Td | 9/1/2002 | P | IM/LA | U0376AA | AVP | 6/10/1994 | 9/1/2002 | RVO |
| Td | 3/1/2003 | P | IM/LA | U0376AA | AVP | 6/10/1994 | 3/1/2003 | TAA |
| Tdap | 3/1/2015 | P | IM/LA | AC52BC02AA | GSK | 2/24/2015 | 3/1/2015 | JA |
| | | | | | | | |
| Hepatitis A6 (e.g., HepA, HepA-HepB) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Hepatitis B6 (e.g., HepB, HepA-HepB) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Human papillomavirus (HPV2, HPV4, HPV9) Give IM.3 | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Measles, Mumps, Rubella (MMR) Give Subcut.3 | MMR | 8/1/2002 | P | Subcut/RA | 0025L | MSD | 6/13/2002 | 8/1/2002 | JTA |
| MMR | 11/1/2002 | P | Subcut/RA | 0025L | MSD | 6/13/2002 | 11/1/2002 | TAA |
| Varicella (VAR) Give Subcut.3 | VAR | 8/1/2002 | P | Subcut/LA | 0799M | MSD | 12/16/1998 | 8/1/2002 | JTA |
| VAR | 11/1/2002 | P | Subcut/LA | 0689M | MSD | 12/16/1998 | 11/1/2002 | TAA |
| Meningococcal ACWY (e.g., MenACWY [MCV4], MPSV4) Give MenACWY IM.7 Give MPSV4 Subcut.7 | MenACWY | 7/12/2011 | P | IM/RA | M28011 | NOV | 1/2/2008 | 7/12/2011 | LTB |
| Menveo | 7/15/2016 | P | IM/LA | M12115 | NOV | 3/31/16 | 7/15/2016 | RVO |
| | | | | | | | |
| Meningococcal B (e.g., MenB) Give MenB IM.7 | MenB | 1/14/2016 | P | IM/LA | J296203 | PFR | 8/14/2015 | 1/14/2016 | RVO |
| Trumenba | 3/15/2016 | P | IM/LA | J296203 | PFR | 8/14/2015 | 3/15/2016 | RVO |
| Trumenba | 7/15/2016 | P | IM/RA | J296203 | PFR | 8/14/2015 | 7/15/2016 | RVO |
See page 2 to record influenza, pneumococcal, zoster, Hib, and other vaccines (e.g., travel vaccines).
## How to Complete this Record
1. Record the generic abbreviation (e.g., Tdap) or the trade name for each vaccine (see table at right).
2. Record the funding source of the vaccine given as either F (federal), S (state), or P (private).
3. Record the route by which the vaccine was given as either intramuscular (IM), subcutaneous (Subcut), intradermal (ID), intranasal (NAS), or oral (PO) and also the site where it was administered as either RA (right arm), LA (left arm), RT (right thigh), or LT (left thigh).
4. Record the publication date of each VIS as well as the date the VIS is given to the patient.
5. To meet the space constraints of this form and federal requirements for documentation, a healthcare setting may want to keep a reference list of vaccinators that includes their initials and titles.
6. For combination vaccines, fill in a row for each antigen in the combination.
| Abbreviation | Trade Name and Manufacturer |
| Tdap | Adacel (Sanofi Pasteur); Boostrix (GlaxoSmithKline [GSK]) |
| Td | Decavac, Tenivac (Sanofi Pasteur); generic Td (MA Biological Labs) |
| HepA | Havrix (GSK); Vaqta (Merck) |
| HepB | Engerix-B (GSK); Recombivax HB (Merck) |
| HepA-HepB | Twinrix (GSK) |
| HPV2 | Cervarix (GSK) |
| HPV4, HPV5 | Gardasil, Gardasil 9 (Merck) |
| MMR | MMRII (Merck) |
| VAR | Varivax (Merck) |
| MenACWY | Menactra (Sanofi Pasteur); Menveo (GSK) |
| MPSV4 | Menomune (Sanofi Pasteur) |
| MenB | Bexsero (GSK); Trumenba (Pfizer) |
===== PAGE 4 =====
Patient name Mahamud Omar
Birthdate 5/31/1971 Chart number
| Vaccine | Type of Vaccine1 | Date vaccine given (mo/day/yr) | Funding Source (F,S,P)2 | Route3 and Site3 | Vaccine | Vaccine Information Statement (VIS) | Vaccinator5 (signature or initials and title) |
| Lot # | Mfr. | Date on VIS4 | Date given4 |
| Influenza (e.g., IIV3, IIV4, ccIIV3, RIV3, LAIV4)\nGive IIV3, IIV4, ccIIV3, and RIV3 IM.3\nGive LAIV4 NAS.3 | Fluoval | 10/2/2009 | F | IM/RA | 2F600411 | GSK | 8/11/09 | 10/2/09 | PWS |
| H1N1 | 12/7/2009 | P | IM/RA | 10092224P | NOV | 10/2/09 | 12/7/09 | DLW |
| Afluoria | 9/12/2010 | P | IM/RA | 06949111A | CSL | 8/10/10 | 9/12/10 | TAA |
| Fluaval | 10/1/2011 | P | IM/LA | 2F600411 | GSK | 8/10/11 | 10/1/11 | JTA |
| IV3 | 9/5/2012 | P | IM/RA | M50907 | CSL | 7/2/12 | 9/5/12 | KKC |
| RIV3 | 12/2/2013 | P | IM/RA | 350603F | PSC | 7/26/13 | 12/2/13 | DCP |
| IV4 | 10/5/2014 | P | IM/RA | UI196AA | PMC | 8/19/14 | 10/5/14 | JTA |
| IV4 | 11/2/2015 | P | IM/LA | 111773P | NOV | 8/7/15 | 11/2/15 | DCP |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Pneumococcal conjugate (e.g., PCV13) Give PCV13 IM.3 | PCV13 | 11/1/2012 | P | IM/LA | 7-5096-06A | WYE | 4/16/10 | 11/1/12 | CJP |
| Pneumococcal polysaccharide (e.g., PPSV23)\nGive PPSV23 IM or Subcut.3 | PPSV23 | 9/10/2011 | P | IM/LA | 663012/1163X | MSD | 10/6/09 | 9/10/11 | DLW |
| PPSV23 | 9/15/2015 | P | /LA | 663860/1626X | MSD | 4/24/15 | 9/15/15 | TAA |
| Zoster (HZV) Give Subcut.3 | | | | | | | | | |
| Hib Give IM.3 | AcHIB | 11/1/2011 | P | IM/RA | D05561 | PMC | 2/4/14 | 11/1/14 | MAT |
| Other | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
See page 1 to record Tdap/Td, hepatitis A, hepatitis B, HPV, MMR, varicella, MenACWY, and MenB vaccines.
## How to Complete this Record
1. Record the generic abbreviation (e.g., Tdap) or the trade name for each vaccine (see table at right).
2. Record the funding source of the vaccine given as either F (federal), S (state), or P (private).
3. Record the route by which the vaccine was given as either intramuscular (IM), subcutaneous (Subcut), intradermal (ID), intranasal (NAS), or oral (PO) and also the site where it was administered as either RA (right arm), LA (left arm), RT (right thigh), or LT (left thigh).
4. Record the publication date of each VIS as well as the date the VIS is given to the patient.
5. To meet the space constraints of this form and federal requirements for documentation, a healthcare setting may want to keep a reference list of vaccinators that includes their initials and titles.
| Abbreviation | Trade Name and Manufacturer |
| IIV3 (inactivated influenza vaccine, trivalent); IIV4 (inactivated influenza vaccine, quadrivalent); ccIIV3 (cell culture-based inactivated influenza vaccine, trivalent); RIV3 (inactivated recombinant influenza vaccine, trivalent) | Fluarix (GSK); Flublok (Protein Sciences Corp.); Afluria, Fluid, Fluclevax, Fluvirin (Seqirus); FluLaval (GSK); Fluzone, Fluzone Intradermal, Fluzone High-Dose (Sanofi Pasteur) |
| LAIV (live attenuated influenza vaccine, quadrivalent) | FluMist (MedImmune) |
| PCV13 | Prevnar 13 (Pfizer) |
| PPSV23 | Pneumovax 23 (Merck) |
| HZV (shingles) | Zostavax (Merck) |
| Hib | ActHIB (Sanofi Pasteur); Hiberix (GSK); PedvaxHib (Merck) |